Physicians at the Washington University and Barnes-Jewish Heart & Vascular Center have extensive experience and expertise evaluating and treating people who may need transcatheter aortic valve replacement (TAVR).
The microvasculature can be imaged at the bedside with continuous infusion of microbubbles (ultrasound contrast agents) or a slow bolus injection.
Coronary atherosclerosis is a diffuse vascular process and a life-long disease where optimal medical therapy is the foundation for all patients with CAD.
Rahul Deo, MD, PhD and Assistant Professor in the Division of Cardiology at UCSF discusses how a type of facial recognition-based strategy is possible for segmentation within an echocardiogram.
Dr. Mohamed A. Zayed discusses how the AngioVac device offers an alternative to existing therapies that treat venous thromboembolism.
Lindsay Davis, Miss Ohio 2011 and patient advocate for SCA, discusses the importance of making CPR mandatory in high school.
Dr. Phillip Cuculich and Dr. Clifford Grant Robinson discuss noninvasive cardiac mapping and ablation, including understanding the effects of radioablation, what is cardiac radiobiology and how and where to deliver energy.
Dr. Daniel Cooper discusses the importance of choosing the right patient at the right time for catheter ablation, minimizing ICD shocks and erring on the side of early referral to maximize the benefits for the patient.
Dr. Nathan Stitziel discusses when to order genetic testing, how the patient should be evaluated for genetic testing and the genetic causes of SCA.
Dr. Marye Gleva discusses when a patient should wear a cardioverter-defibrillator, the risk factors associated with not wearing one and how a WCD works.
Dr. Pamela K. Woodard discusses at the AHA Conference if patients who have an ICD can have an MRI, the types of ICDs for MRI scanning and the risks of MRI scanning patients with a CIED.
Dr. Mitchell N. Faddis discusses how subcutaneous ICD shocks avoid myocardial injury, if implantation is safe and effective and which patients are the ideal candidates for an SICD.
Chief Medical Officer of Amgen, Paul Eisenberg, MD, discusses the insights he has learned working on drug development, specifically the cardiovacscular drug that lowers LDL, PCSK-9.
University of Alabama cardiologist Vera Bittner, MD, MSPH, discusses the barriers and opportunities in the implementation of optimal medical treatment.
Cleveland Clinic cardiologist Bruce D. Lindsay, MD, FACC, FHRS, gives the viewer insight into the future of atrial fibrillation. Dr. Lindsay discusses the mapping of AF, types of AF and what advances in technology may alter current approaches to ablation
Northwestern University cardiologist Clyde W. Yancy, MD, MSc, discusses heart failure in African Americans, who have a disproportionate burden of heart disease. Dr. Yancy discusses how there is a need for treatment to reduce the effects ...
Understand the benefits and challenges of mechanical circulatory support for endstage heart failure patients and shock patients.
Peripartum Cardiomyopathy remains a serious but incompletely understood cardiovascular complication of pregnancy.
The major diseases affecting the thoracic aorta are aortic aneurysms and acute aortic dissections.
Should you offer genetic testing to your patient with HCM? When you approach genetic testing in patients and families with HCM, it is definitely a shared decision.
Minimally invasive septal myectomy procedures, atrial fibrillation is an under-recognized problem in HOCM patients.
An update on the emergence of Cardiovascular Magnetic Resonance (CMR) in HCM and its impacts on sudden death assessment.
Learn the details of sudden death in HCM to aid in what is often a sobering discussion for patients
HCM, an unexplained hypertrophy not due to some other secondary cause, is a highly variable disease that presents uniquely in each patient.
The scientific community is constantly conducting research and clinical trials to increase the knowledge regarding the manifestation, treatment and prevention of cardiovascular disease.
Coronary Microvascular Function and Diastolic Heart Failure are two epidemics that can explain the disparities in cardiovascular outcomes in women.
To understand invasive techniques for characterization of atherosclerotic plaque and how these influence patient care.
The advent of transcatheter valve therapies has opened up new treatment options and new challenges in patient selection for valve replacement.
This presentation will review age- and hypertension-related changes in blood pressure regulation and how they impact the development of cognitive and mobility impairments in advanced age.
Dr. Philippe Pibarot discusses calcific aortic stenosis, looking at key concepts and towards the future.
Dr. Eric Peterson, Director, Duke Clinical Research Institute, presents The Future of Clinical Cardiovascular Research.
Dr. Kathryn J. Lindley discusses pregnancy and contraception in women with heart disease.
Gain an understanding of the current concepts in managing acute heart failure and understanding the pathophysiology of heart failure, focusing on the relationship to kidney function.
Dr. William Fearon of Stanford University Medical Center presents Limitations of the Coronary Angiogram: More than Meets the Eye.
Dr. George Bakris of the The University of Chicago Medicine presents JNC 8 et al.: Is Evidence-Based Medicine the Only Way?
Dr. Donald M. Lloyd-Jones of Northwestern University Feinberg School of Medicine presents Updated Risk Assessment Guidelines for Cardiovascular Disease.
Return to Barnes-Jewish Hospital